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1. Introduction 
Our experience is related to the treatment of a lifethreating disease (leukaemia) and from it 
should be applicable the same concepts or strategies to any other severe chronic disease. 
Since the early 1970s, a cure for childhood cancer has become a reality: over 80% of cases are 
now cured. Yet, despite the relatively high cure rate, the diagnosis of leukemia continues to 
place a heavy burden on family functioning. The parents must walk the narrow line 
between focusing too much on the child’s disease and treatment and maintaining a normal 
family life. Because cure is such a real possibility, the children must be prepared for a full 
and active participation in adult life, just like their peers. Proper discipline must be 
maintained within as normal a family life as possible. The child’s continued attendance at 
school and participation in normal childhood activities is imperative in the child’s 
preparation for adulthood. 
For all these reasons, psychosocial intervention has become a necessity in the treatment of 
the child, even for those children who eventually will die from the disease. 
Although there is little disagreement that the ultimate goal of treatment for childhood 
cancer is the total cure of the child-medical, educational, psychological, and social-the 
issue is how best to achieve this end. The literature is filled with research-based 
conclusions on which type of psychosocial intervention is best, including when and how 
one should communicate with the child about the diagnosis, how to help the parents 
maintain some sense of normality in their family life, how to help the child return to 
school, how to keep the siblings informed, how to start parent groups, how to involve 
parents in medical decision-making, how to prepare for the terminal phase when it occurs 
for some children, and how to continue to monitor long-term survivors. Problems occur 
whenever the approach must be modified to meet the needs and cultural preparation and 
expectations of the children and their families. This is especially true when one tries to 
apply conclusions that are appropriate in one culture to other centers and to other 
cultures. 
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What works in one cultural setting may not work as well in others. How might a center 
apply programs from one country or setting to another? Not all hospitals can afford a 
psychosocial team.  
Not all cultures appreciate intervention by a psychologist or psychiatrist. What can pediatric 
hematologists do to modify their approach to the children and their families with maximal 
success, in a manner most appropriate to and respectful of the needs of the families within 
their own cultural setting? And above all, how can a center best monitor its intervention 
programs, to ensure that the needs of the children and their families are being met 
appropriately, in their best interests, and with greatest effectiveness and use of resources? 
How do we help a family whose child has been diagnosed with a life-threatening illness? 
How do we help the children and their families cope with the illness and its treatment? As 
the medical treatment of childhood cancer has moved from an inevitable death sentence to 
an approximately 80% cure rate, the importance of including the psychosocial in the 
treatment of the children has now been so integrated that the majority of the pediatric 
cancer centers throughout the world now view treatment as a biopsychosocial process. 
From the very beginning, with the shock of the diagnosis itself, the children and their 
families undergo a critical change in their lives. The illness has a high social and economic 
cost, even if the treatment itself is done free of charge to the families. Whether the child is 
treated in countries with limited resources or in the wealthier countries, personal, family, 
and cultural circumstances can block access to a full cure, a cure that treats the child at all 
levels:  medical, psychological and social. As the families face the task of adjustment to this 
new reality, with the support of the hospital health care team the families can find a source 
of renewed energy and the inner strength to cope with the disease and the treatment 
process.  
Each phase of treatment has its own characteristic that contribute to the reaction of parents 
and children. The phases are the following: acute phase, during treatment, after treatment, 
long-term follow-up, end-of-life. 
2. A Multidisciplinary effort: Type of strategy in all the phases of the disease 
From the earliest years, the effort to care for the child with cancer has been 
multidisciplinary, multi-institutional, and international, involving a highly cooperative and 
collaborative effort of physicians, nurses, psychologists, social workers, and allied health 
care professionals all working together across national borders. When, thirty years ago, 
physicians treating the children found themselves struggling with the psychological and 
social repercussions of the cancer on their young dying patients and their families issues 
that ranged far beyond their medical expertise and training, psychosocial practitioners 
helped in dealing with these broader human concerns. The pediatric oncologists and 
hematologists from countries throughout the world began working cooperatively with 
psychiatrists, social workers, nursing care specialists, and psychologists. To the credit of all 
involved, this cooperative multidisciplinary, multi-institutional and international effort has 
been from the very earliest years and continues to be the hallmark of the treatment of 
childhood cancer. It is important that all members of the health care team engage in 
psychosocial support, and not just the psychosocial personnel. 
www.intechopen.com
How to Accompany Children and  
Parents During the Different Phases of a Severe Chronic Disease 
 
255 
3. Research: Psychosocial research is essential to build up different clinical 
approaches 
The primary psychosocial concern in child cancer care is to help the children and their 
families cope with the diagnosis of cancer and its aftermath. The children and their families, 
the great majority of whom are struggling with the new diagnosis but who do not show 
signs of falling apart, need our support. How can we most effectively help mentally healthy 
children whose lives have been suddenly turned upside down with the diagnosis of a life-
threatening illness? We can’t expect the families to wait for intervention until we can fully 
determine which intervention works most effectively and validly. We must try to help the 
child and family who have an immediate here-and-now need for support, while pursuing 
scientifically valid controlled research designed to sort out effective from ineffective 
interventions. The optimal clinical service is the application of the best available evidence-
based findings applied locally in cultural context. Well done research is costly and difficult 
to accomplish in centers with limited resources. However, the health care team even a center 
with limited resources can listen carefully to the children and their families to find out how 
they are functioning and how they are responding to the service that is offered. It is 
recommended that parents be asked formally how well they view the center’s functioning 
and this satisfaction within a simple nonrandomized like study. Modifying one’s approach 
based on a reflection on the families’ level of satisfaction with the service can help make the 
service better. Even in countries with limited resources, it is possible and critically essential 
to give full attention to the psychosocial needs of the children and their families.  
4. Alliance between parents and physicians: The basis in all the phases of 
the disease 
It is clear that a hospital health care team can not do it all. Parents should be invited 
increasingly to participate actively in their child’s medical, psychological and social care, 
brought in as part of the decision-making process and support system. There should be a 
healthy, cooperative, and open alliance between the parents and the members of the health 
care team, including the establishment of parent groups for self-help and for raising 
supplementary and critical funding.  
Wasteful expenditure of negative energy by anyone involved might be more profitably 
used, and in turn mobilize new and even more powerful positive energies, by cooperating 
toward fighting the disease in a therapeutic alliance. This alliance may take one or both of 
two forms: (a) an alliance between individual family members parents and children and 
individual medical staff members; and (b) an alliance between families as a group and 
health care team members as a group. These therapeutic alliances are formed when both 
parties work together with a common purpose pooling resources toward a common goal: 
curing the cancer and minimizing its medical and psychosocial side-effects, and mobilizing 
the energies of all members of society to this end. 
The role of physicians and health care team members working together in cooperation with 
parents as equal partners is to: 
1. Dedicate time, energy and creativity to collaborate with parent associations by 
suggesting and arranging joint meetings and acting in advisory capacities. 
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2. Encourage all parents, especially shy or cautious parents, to join a parent association 
and help activate parents to organize such associations where they do not already exist. 
3. Have parent association members, together with members of the health care team, 
cooperate in deciding upon a global medical, psychosocial and social-cultural 
intervention program, toward which they all can converge their united energies. 
4. Do all in their power to ensure that cured children and young adults are successfully 
reintegrated into society, without being penalized in school, work, social relations or 
insurability for having had cancer as a child.  
5. Open communication: At diagnosis, during treatment, at the end of life 
Communicating the diagnosis and how best to do is the first step in a communicative 
process and relationship that involves the medical team and the family, and that allows for 
growth and change over time. As the evidence mounts that the children, siblings, and 
parents would be best served by being encouraged to bring into the open their anxieties 
about the illness and its possible consequences, studies have been paying more attention to 
how parents and medical personnel communicate with the child. The initial diagnosis is a 
model for all future interchanges of information between the medical professionals and 
families and between the family members themselves, especially between parent and child. 
As the families of the children diagnosed with cancer struggle to face the new emotional 
crisis which is challenging the relationships among the family members and the very 
balance of family life, we need to help the families strengthen their coping skills, alleviate 
their anxiety and offer the type of support the children and families are seeking, in specific 
ways that are most important to the children and families at a given moment. Basic to 
effective family coping is the belief that communication of both happy and painful thoughts 
and feelings, by the parents and by the children, is a healthier state of mental well being 
than retaining those thoughts in silence. This belief is a prerequisite to mutual support 
among family members. The families which allow open discussion of the illness and its 
prognosis are able to cope more effectively with the illness within their own family, and are 
also able to give and receive the support of other parents in the clinic.  
Management of this communicative process has an important influence on how all involved 
child, parents, other family members, and medical staff work and care for the child together. 
At diagnosis the child and family’s level of anxiety is very high, and their level of prior 
information and understanding varies greatly. Most parents want to know as much as 
possible about the disease, treatment procedures, prognosis, practical coping details, and 
emotional impacts. The staff’s communication of the diagnosis and treatment plan should be 
done in a way that is responsive to these needs, and that develops confidence and trust 
among the pediatric cancer staff, patient and family. 
Our general view is that full and open communication between the medical care team and 
the family (including the child), and within the entire family, is the ideal situation. However, 
this is not always possible or preferable. It also must be done in a way that is sensitive to 
different cultural styles and preferences. 
The communicative session should be conducted in a private space, with comfortable 
seating and an environment conducive to discussion of painful issues, as a conversation 
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between equals. Both parents and the chairman or a senior medical staff member should be 
present, as well as the head nurse or another staff member. The attendance of the family’s 
local physician should be encouraged unless parents do not agree. If requested the child 
with cancer (according to age), other family members (e.g. grandparents: they are significant 
sufferers that often receive little attention!) or close friends also may attend this session. 
When communicating with the child, the physician should explain the disease at the level of 
development of the child, using pictures and analogies such as the flower garden to help the 
child’s understanding. The physician should make sure that the dialogue is truly a two-way 
interaction, with the child invited to ask questions and having the answers explained as 
clearly as possible. Depending on age and level of development, the physician should talk to 
the siblings as well, explaining to them the basic elements of the disease and its treatment, 
and having them as well communicate back to the parents what they understand about the 
illness. In this way, an open system of communication is set up within the family.  
6. The siblings: At diagnosis, during treatment, over the time 
From the earliest intervention periods, the health care team members have all they can do, 
first to focus on the needs of the children with cancer, and then on the needs of the parents. 
The parents are overwhelmed by their concerns for the sick child, giving their immediate 
and full attention to the medical treatment of their sick child. Without any ill intention on 
the part of already overburdened parents, siblings are often inadvertently ignored. We 
should try to give attention to the needs of the siblings as well, and not let them be 
forgotten. During this time of crisis, when the parents are already giving their almost 
undivided attention to the sick child, how does one bring the needs of the siblings to 
parents’ attention? How does one encourage and help the family to return to as normal a 
family life as possible as soon as possible? There are general principles for helping take care 
of the needs of siblings that apply throughout the treatment process, and there are 
principles specific to each phase of treatment: what to expect both for themselves and for 
their brother or sister now versus after physical changes occur, or changes in their 
relationships with their brother, sister, and parents, and what they can do to help during 
these transitions; and what adverse effects the siblings might have on the patient (for 
example, “spreading germs,” e.g., a cold, or picking fights). Members of the health care team 
can speak with parents about the need to support the siblings, despite all of the other 
burdens that go into caring for the ill child. They can encourage the parents to share and 
generate suggestions regarding how to involve the siblings from the very beginning. Parents 
need to communicate with and listen to siblings. As an instinctively human reaction, in the 
absence of factual information, siblings tend to fear the worst, even for their own health. 
When parents and members of the health care team attempt in good faith to shield the 
siblings from knowledge about the illness, such well-intentioned hiding of the truth often 
drives the siblings to fear even worse possibilities, and can lead to feelings of isolation, guilt, 
and resentment. 
At the time of diagnosis, health care team members and other parents when feasible should 
share with the parents of a newly diagnosed child the need to keep siblings informed from 
the very beginning, demystifying the illness and the treatments; parents should be 
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encouraged to bring the siblings to the hospital if the siblings wish to go, let them visit with 
their brother or sister, and let them see how the hospital looks; parents should be 
encouraged to explore the benefits of immediately telling the siblings, and should help 
choose which person will be the one to inform the siblings, using simple and age-
appropriate language and phrasing when delivering the news of the diagnosis; and siblings 
should have explained to them that they were in no way responsible for causing the cancer.  
7. Living a normal life/back to school: During treatment 
Improvements in the ability of medical care made it possible for children diagnosed with 
cancer to live longer and, in increasing frequency, to be cured. The children are able, 
while in remission, to live a relatively normal life, somewhat free of their concerns about 
their illness. We need to help the children to engage in the educational and social 
activities that accompany normal growth and development . It is not enough for young 
people simply to survive what was once a life-threatening illness. Survival means that the 
children have to continue to be educated toward one day becoming fully functioning 
adult members of society. Thus, parents and professionals have the increasing 
responsibility of promoting sound academic and social development as the children go 
through the treatment process.  
Going back to school has a very normalizing influence on the child. Integration into school is 
a critical and essential part of the normal psychological and social development of any child. 
Children with cancer are not only entitled to attend school, but they must be stimulated to 
do so. Even while in the hospital, children should continue their schooling, as an indication 
to them of hope for cure, that their life will continue as normal, despite the illness. Programs 
should be developed to help the children continue their schooling while in the hospital, and 
to help them return to their normal life as school children as soon as possible, and their 
teachers trained to treat the children as normally as possible. We should pay special early 
attention to patterns and difficulties of socially adaptive behavior in the children and most 
importantly be aware of the strong link between the use of cranial radiation and subsequent 
learning deficits. As a group, children with cancer function at less socially adapted levels in 
school than peers, have a tendency not to reach out to others, not to initiate activities, not to 
try new things, and not to express feelings freely. The children retain a self-protective 
attitude. And so, in addition to already being devastated by the emotional stresses 
associated with a child having cancer and undergoing what to them were extraordinary 
medical treatments, we know that the cognitive side effects of the therapy place a group of 
the children at a higher risk not only for learning difficulties, but also for subsequent 
adaptive behavioral problems. 
We cannot freeze children for years during treatment while their peers continue to grow and 
develop, leaving the children with cancer developmentally far behind and in a catch-up 
mode. We must prepare children for their future. Not only should we give priority to the 
children continuing to live a normal life during the course of treatment, we have in fact 
come to view childhood cancer as a golden opportunity for the children to learn skills in 
coping that can give them a running start on their preparation for engaging in a fully 
functioning adulthood.  
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8. Long-Term survivors or better “cured” subjects: After treatment, long-term 
follow-up 
How well are the children responding to the increasingly successful treatments? Programs 
oriented to the needs of the long-term survivor should begin when the child goes off 
therapy, with centers focusing on the sequelae specific to each form of illness, treatment, 
toxicity, and future problems specific to each child’s needs. Centers should offer counseling 
programs for the more serious medical and psychosocial problems, adapted to the need of 
each individual and local culture. Centers should develop specialty clinics, managed by the 
pediatric oncologist who treated the children, and having available a full range of adult and 
young adult specialists as consulting physicians. Each long-term survivor should be 
monitored for special conditions related to their unique history as well as their age-specific 
developmental concerns. Programs should include psychological counseling for the 
survivors experiencing adjustment difficulties and significant side effects.  
As medicine continues to achieve an increasingly higher success rate in long-term survival, 
we should follow survivors to determine further potential long-term sequelae. The long-
term role of each pediatric hematology/oncology center is to follow the survivors until there 
is assurance that the child will have no further long-term sequelae. It is important and 
critically necessary to follow the child until the disease is considered “cured” (at about five 
years). After that time, one should not over-medicalize the survivor, but help the child to 
make the transition to normal health-care status. When specific sequelae (such as heart 
problems) are known for a particular child, that child should be followed for the issue of 
concern specific to that child.  
The clinic should keep a careful computerized record of essential data particular to each 
survivor so that in the future, when the now-adult survivor is seen by an adult physician, 
the data on the survivor’s previous cancer experience will be available upon request.  
Psychological research studies that have followed the survivors of childhood cancer for many 
years after successful treatment have found, not only that the now-adult-survivors are doing 
well, but that in many way having learned from the challenges of their childhood cancer 
experience they are better prepared for the more pressing challenges of adulthood than are 
their peers. The so-defined resilience is not an utopia but a always more visible reality.  
9. Impending death: At the end of life 
Despite the remarkable growth in the percentage of cures and the increasing sense of hope 
being given to newly diagnosed children and their families, many of the children are not 
able to be cured. Death for some remains a reality. There are three periods of time 
surrounding this final phase of life that have become the subjects of research. The first is the 
period when treatment is judged to be no longer effective and the difficult decision is made 
to move from curative intent to the palliative phase of care. The second is the period from 
the beginning of palliative care to the death of the child. The third is after the child dies, 
with the staff counseling the parents in their grief following the death of their child.  
A child with cancer is considered by his/her physician to be moving from curative to 
palliative care when the child cannot be successfully treated by presently available 
therapies, and the child needs specific treatments, identified to be palliative and not 
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curative, for physical or mental distress. There can be a long delay between the moment 
when the physician determines that the child will not be cured and the moment when 
everyone involved agrees that the child has entered the last or final phase of life. 
In managing this transition from the curative to the palliative phase of the child’s treatment, 
it is critical to protect the child. The expectations of the family must be considered to help 
them avoid feelings of guilt for not having done everything possible. However, a real 
dilemma is created for everyone if aggressive therapy is continued when the possibilities of 
cure are virtually not existent. 
The decision to move from the intent to cure to palliative care should be made with the 
parents and the full health-care team, certainly including the nurses. Depending on age and 
level of development, the child should also be involved in the decision, with older children 
especially participating more actively. The child should know as much as possible and 
developmentally appropriate about the seriousness of his/her situation. However, if the 
child wishes to remain less informed, this wish should be respected, and whatever 
information is given should allow the child to retain a margin of hope. 
The continuation of curative treatment beyond the point when cure is no longer possible 
should be avoided (the so-called ‘‘ruthless obstinacy’’ treatment). 
After a child dies, that individual child’s medical history should be evaluated. This 
evaluation should be made by the health-care team as a group. It is very important to reflect 
on all events, even minor ones, that occurred during the course of the child’s treatment. It is 
critical to reflect on the choices that were made and why, in order to help the staff come to 
terms with their own grieving and to learn from the experience in order to help future 
families. 
The center’s health-care team should be prepared to modify its overall philosophical goals 
and reset directions and guidelines when appropriate, based on such review of individual 
cases and parental comments. 
After the child dies, hospitals should offer bereavement counseling on the part of physicians 
and nurses to help clarify past care and guide future grieving. Parents and siblings, when 
appropriate, can be invited to discuss with the physician both the level of care and the 
surviving family members’ current needs. A first-step aid to bereavement is for the 
physician, about three to four months after the child dies, to call back the parents (and 
siblings, when age-appropriate) and to discuss with them the details of the terminal phase, 
to help them work through their understanding of what happened. If at this point, some 
families need further help in grieving, they can be referred to parent-self-help grieving 
groups or to one-on-one therapy. For the majority of the families, the one follow-up 
interview appears to be a sufficient step in helping them to move forward through the 
grieving process. 
10. Final recommendations for application: Since diagnosis on 
Psychosocial interventions have become so fully incorporated into the care of children with 
cancer that they are now considered, not just an appendage, but a critical component in the 
care of the child with cancer. Where do we go from here?  
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1. As we health care professionals become more experienced in dealing with the children 
with cancer and their families, we cannot forget that for each newly diagnosed family, it 
is truly all brand new. Each case is individual. We should continue to bring to the 
newly diagnosed children and their family a fresh sensitivity that acknowledges the 
newness of their experience.  
2. Children, even the youngest, sense the seriousness of their illness. They pick up the 
fears and anxieties of the adults around them. They do their best to communicate with 
us, at all ages. Even the youngest try to talk to us, often without words, often just by 
their body language. How well do we listen? Do we truly listen? We need to develop 
more effective ways of attending to what the children are experiencing and their mode 
of communicating that awareness. 
3. Many of our interventions have proceeded far ahead of our success in measuring their 
effectiveness. While many new instruments have been developed and older 
instruments have been creatively applied specific to the study of the children and their 
families, we need to continue this creative effort and plunge more deeply into the study 
of the effectiveness of our interventions. 
4. Parent groups are critical to the continued success of each clinic’s efforts, not only by 
forming support services for one another on mutual psychosocial needs, but as 
importantly in teaming with physicians in raising funds to keep the clinic up-to-date 
and growing both in research and in intervention. Health care professionals and parents 
should strengthen their alliance, making it a priority to continue sharing decision-
making, not only in individual cases, but in parental support of the clinic’s growth. 
5. Among the newly diagnosed families, there will be a small percentage 15% or so who 
bring with them pre-diagnosis problems that can seriously interfere with the child’s 
treatment. We should continue to develop ways to help identify these families at the 
very beginning, so that we can refer them for the extra psychosocial help that they will 
need in order to cope with the treatment. With our remaining resources, we will then be 
better able to help the families who bring with them a stronger history of coping 
abilities and who are less encumbered by long-standing behavioral, social, financial, or 
legal problems. 
6. Burnout is a very serious possibility for those working with children with cancer and 
their families. Acknowledging this very real fact and talking about it openly within the 
health care team can help prevent serious burnout and alleviate the milder and more 
subtle forms of burnout.  
7. While there is an ongoing need for professionals to publish their findings in refereed 
journals, it is equally important to translate these findings into readable, clear, and 
simple booklets or pamphlets for the children, for their parents, and for their teachers. 
We owe it to the children and their families to continue developing clear and simply 
written booklets that can help explain some of the complexities of the treatment in ways 
that they can understand. 
8. Much of our psychosocial long-term follow-up study during these past years has 
focused on potential negative sequelae of the illness and how best to prevent and/or 
ameliorate them. The next step in helping the children as they grow into adulthood 
should be to focus on the potential for growth associated with their illness. The 
children-becoming-young-adults, by overcoming their illness,  have a golden 
opportunity to develop their skills in coping and learning to deal with future life’s 
problems as they enter adulthood. 
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9. Medicine advances most effectively by narrowing its scope. Psychology advances by 
broadening its scope and generalizing to theory. Both together are necessary in the 
treatment of the child with cancer. As we continue to develop the research and 
intervention efforts with the children with oncological and hematological illnesses, we 
have seen our biopsychosocial efforts become a model for the increasing integration of 
the psychosocial in the treatment of children with a variety of chronic illnesses (Roberts, 
2003). We should continue to disseminate our research and intervention findings 
among pediatric practitioners who are dealing with similar issues in different settings 
and with different chronic childhood illnesses.  
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